Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.540
-0.100 (-6.10%)
At close: Feb 21, 2025, 4:00 PM
1.530
-0.010 (-0.65%)
After-hours: Feb 21, 2025, 7:59 PM EST
PACB Revenue
In the year 2024, Pacific Biosciences of California had annual revenue of $154.01M, down -23.19%. Pacific Biosciences of California had revenue of $39.22M in the quarter ending December 31, 2024, a decrease of -32.79%.
Revenue (ttm)
$154.01M
Revenue Growth
-23.19%
P/S Ratio
2.74
Revenue / Employee
$193,485
Employees
796
Market Cap
453.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 154.01M | -46.51M | -23.19% |
| Dec 31, 2023 | 200.52M | 72.22M | 56.29% |
| Dec 31, 2022 | 128.30M | -2.21M | -1.69% |
| Dec 31, 2021 | 130.51M | 51.62M | 65.43% |
| Dec 31, 2020 | 78.89M | -12.00M | -13.20% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
PACB News
- 3 days ago - PacBio to Participate in TD Cowen's 45th Annual Health Care Conference - GlobeNewsWire
- 7 days ago - PacBio Grants Equity Incentive Award to New Employee - GlobeNewsWire
- 8 days ago - Pacific Biosciences of California, Inc. (PACB) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Trump's Cuts to Medical Research Are Hurting These Stocks - Barrons
- 19 days ago - PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service - GlobeNewsWire
- 23 days ago - PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025 - GlobeNewsWire
- 23 days ago - PacBio Announces Appointment of Chris Smith to Board of Directors - GlobeNewsWire
- 24 days ago - PacBio Technology Powers Landmark Multiomic Study Published in Nature Genetics - GlobeNewsWire